Shares of Apollo Hospitals Enterprise Ltd fell by over 3.7% on Tuesday, February 11, to ₹6,506, even after reporting a 49% year-on-year (YoY) increase in net profit to ₹379.4 crore for Q3 FY25. The strong bottom-line growth was attributed to higher revenues and operational efficiencies, although investor sentiment appeared cautious.
The company’s revenue for the quarter stood at ₹5,526.9 crore, reflecting a 13.9% YoY increase. While revenue growth met market expectations, EBITDA stood at ₹761.4 crore, rising 24% YoY but falling short of the estimate of ₹771.6 crore. Operating margins improved to 13.8% from 13% YoY but remained below the expected 14%.
Apollo Hospitals also announced an interim dividend of ₹9 per share. Analysts maintain a positive long-term outlook, highlighting its strategic focus on digital health and AI collaborations to enhance services and drive growth.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your research or consult a financial advisor before making investment decisions. The author or Business Upturn is not liable for any losses arising from the use of this information.
